
Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proposition? A study from kashmir
Author(s) -
Farah Sameem,
Iffat Hassan,
Qazi Masood Ahmad,
Dilshad Khan,
Imran Majeed,
MA Kamili,
P Shah
Publication year - 2010
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.74543
Subject(s) - medicine , dexamethasone , dysphagia , systemic therapy , disease , surgery , cancer , breast cancer
Systemic sclerosis is a multisystemic autoimmune disorder. Intravenous dexamethasone pulse therapy has been used since 1998.